+ Follow UNIVERSALLY ACCESSIBLE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 779853
[Title] => Price cuts eyed for more cancer drugs
[Summary] => To boost the campaign against cancer, the Department of Health (DOH) is now studying other anti-cancer drugs that can be subjected to mandatory price reduction.
[DatePublished] => 2012-02-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 439650
[Title] => This good news should travel fast!
[Summary] => Good news very rarely hits the news nowadays.
[DatePublished] => 2009-02-13 00:00:00
[ColumnID] => 135937
[Focus] => 0
[AuthorID] => 1444024
[AuthorName] => Korina Sanchez
[SectionName] => Freeman Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 432100
[Title] => Prices of medicine seen dropping with stiff competition
[Summary] => Sen. Manuel Roxas II sees prices of medicine dropping with the arrival of a giant India-based pharmaceutical firm.
[DatePublished] => 2009-01-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[3] => Array
(
[ArticleID] => 67935
[Title] => EDITORIAL – Next battleground
[Summary] => The law meant to bring down the prices of medicine was one of the few pieces of legislation passed during the first session of the 14th Congress. The law was approved amid intense lobbying by interested parties, notably pharmaceutical giants, against certain provisions of the measure.
[DatePublished] => 2008-06-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
UNIVERSALLY ACCESSIBLE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 779853
[Title] => Price cuts eyed for more cancer drugs
[Summary] => To boost the campaign against cancer, the Department of Health (DOH) is now studying other anti-cancer drugs that can be subjected to mandatory price reduction.
[DatePublished] => 2012-02-23 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 439650
[Title] => This good news should travel fast!
[Summary] => Good news very rarely hits the news nowadays.
[DatePublished] => 2009-02-13 00:00:00
[ColumnID] => 135937
[Focus] => 0
[AuthorID] => 1444024
[AuthorName] => Korina Sanchez
[SectionName] => Freeman Opinion
[SectionUrl] => opinion
[URL] =>
)
[2] => Array
(
[ArticleID] => 432100
[Title] => Prices of medicine seen dropping with stiff competition
[Summary] => Sen. Manuel Roxas II sees prices of medicine dropping with the arrival of a giant India-based pharmaceutical firm.
[DatePublished] => 2009-01-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[3] => Array
(
[ArticleID] => 67935
[Title] => EDITORIAL – Next battleground
[Summary] => The law meant to bring down the prices of medicine was one of the few pieces of legislation passed during the first session of the 14th Congress. The law was approved amid intense lobbying by interested parties, notably pharmaceutical giants, against certain provisions of the measure.
[DatePublished] => 2008-06-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
January 17, 2009 - 12:00am
